Intrinsic Value of S&P & Nasdaq Contact Us

Ayala Pharmaceuticals, Inc. ADXS OTC

Other OTC • Healthcare • Biotechnology • US • USD

SharesGrow Score
26/100
1/6 Pass
SharesGrow Intrinsic Value
N/A
Negative cash flow

Stock Statistics — ADXS

Ayala Pharmaceuticals, Inc. (ADXS) has a market capitalization of $25.71M and trades at $0.60. The 52-week range is 0.0011-0.801.

Key metrics include a trailing Price-to-Earnings (P/E) ratio of -0.1, Earnings Per Share (EPS) of $-7.99, annual revenue of $13K.

The stock has a beta of -4.03, operates in the Healthcare sector.

Trading Data
Current Price$0.60
52-Week Range0.0011-0.801
Volume10.01K
Avg Volume (30D)5.05K
Market Cap$25.71M
Beta (1Y)-4.03
Company
IPO Date2020-05-08
Employees20
CEOKenneth A. Berlin
CountryUS
ExchangeOther OTC
CurrencyUSD
ISINUS0076244062
CUSIP007624307
Income (Latest Year)
Revenue$13K
EBITDA$-35.87M
Operating Income$-36.27M
Net Income$-48.07M
EPS$-7.99
EPS Diluted$-7.99
Shares Outstanding$6.02M
Balance Sheet (Latest Year)
Total Assets$16.58M
Current Assets$7.53M
Cash & ST Investments$4.88M
Total Liabilities$41M
Total Debt$8.32M
Net Debt$3.43M
Total Equity$-24.42M
Debt / Equity-0.34
Valuation Ratios
P/E Ratio-0.1
P/S Ratio1977.51
Contact Us
🎓
SharesGrow Academy
Learn how to calculate Intrinsic Value and find undervalued stocks.
Weekly live sessions
Send us a message